Translational Development Acquisition Corp
Officers & Directors
Michael B. Hoffman serves as Chairman of the Board of Directors at Annovis Bio, Inc., a company focused on drug development for Alzheimer's and Parkinson's diseases, and is a Principal at Stone Capital Partners, an investment platform he founded. Avanindra C. Das is a Principal and Advisor at Stone Capital Partners. E. Premkumar Reddy is a Professor at the Icahn School of Medicine at Mount Sinai and the Founder, President, and Director of AACT Inc., a drug development company, as well as Founder and Director of Althenova Therapeutics Inc., a biotechnology company. Curtis T. Keith is the Chief Scientific Officer at the Blavatnik Biomedical Accelerator at Harvard University. Matthew A. Kestenbaum is Managing Director at EQT, an alternative asset management firm, and serves on the Investment Committee at EQT Foundation. Christopher Jarratt is a former Director and Vice Chair at Algonquin Power & Utilities Corp., a power and utilities company.
|
